title: Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid.
authors: Department of Dermatology, University of Münster, Münster, Germany.
authors: Sarah
authors: S
authors: Schulz
authors: Dirk
authors: D
authors: Deuster
authors: Enno
authors: E
authors: Schmidt
authors: Gisela
authors: G
authors: Bonsmann
authors: Stefan
authors: S
authors: Beissert
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D015815:Cell Adhesion Molecules / Q000276:immunology*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010390:Pemphigoid, Benign Mucous Membrane / Q000188:drug therapy* / Q000276:immunology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D000097794:Kalinin
chemical_list: D001323:Autoantibodies; D015815:Cell Adhesion Molecules; D000068800:Etanercept; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000097794:Kalinin